Authors: Tegeder, I Niederberger, E Israr, E Guhring, H Brune, K Euchenhofer, C Grosch, S Geisslinger, G

Citation: I. Tegeder et al., Inhibition of NF-KB and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15(3), 2001, pp. 595-597

Authors: Grosch, S Tegeder, I Niederberger, E Brautigam, L Geisslinger, G

Citation: S. Grosch et al., COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib, FASEB J, 15(12), 2001, pp. NIL_300-NIL_321

Authors: Tegeder, I Niederberger, E Israr, E Guhring, H Brune, K Euchenhofer, C Grosch, S Geisslinger, G

Citation: I. Tegeder et al., Inhibition of NF-kappa B and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15(1), 2001, pp. 2-4

Authors: Grosch, S Niederberger, E Lotsch, J Skarke, C Geisslinger, G

Citation: S. Grosch et al., A rapid screening method for a single nucleotide polymorphism (SNP) in thehuman MOR gene, BR J CL PH, 52(6), 2001, pp. 711-714

Authors: Tegeder, I Niederberger, E Vetter, G Brautigam, L Geisslinger, G

Citation: I. Tegeder et al., Effects of selective COX-1 and-2 inhibition on formalin-evoked nociceptivebehaviour and prostaglandin E-2 release in the spinal cord, J NEUROCHEM, 79(4), 2001, pp. 777-786

Authors: Hoessel, R Leclerc, S Endicott, JA Nobel, MEM Lawrie, A Tunnah, P Leost, M Damiens, E Marie, D Marko, D Niederberger, E Tang, WC Eisenbrand, G Meijer, L

Citation: R. Hoessel et al., Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases, NAT CELL BI, 1(1), 1999, pp. 60-67